Globe Life (NYSE:GL) CFO Thomas Peter Kalmbach Sells 21,000 Shares

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 21,000 shares of Globe Life stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer owned 50,568 shares of the company’s stock, valued at $9,105,274.08. The trade was a 29.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Tuesday, July 28th, Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00.
• On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The shares were sold at an average price of $156.59, for a total transaction of $1,242,698.24.
• On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The shares were sold at an average price of $156.61, for a total transaction of $1,864,128.83.
• On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80.
• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05.

Globe Life Price Performance

NYSE GL opened at $182.65 on Friday. The company has a market cap of $14.18 billion, a PE ratio of 12.13 and a beta of 0.47. The firm’s 50 day moving average price is $171.01 and its 200-day moving average price is $154.07. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period last year, the firm earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Sell-side analysts forecast that Globe Life Inc. will post 15.7 EPS for the current fiscal year.

Hedge Funds Weigh In On Globe Life

A number of large investors have recently made changes to their positions in GL. Tudor Investment Corp ET AL acquired a new stake in shares of Globe Life in the 3rd quarter worth $7,348,000. Jupiter Asset Management Ltd. acquired a new position in Globe Life during the 4th quarter valued at about $2,073,000. Northwestern Mutual Wealth Management Co. increased its position in Globe Life by 34,786.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after buying an additional 879,391 shares in the last quarter. Vanguard Group Inc. raised its stake in Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after buying an additional 86,349 shares during the last quarter. Finally, Strs Ohio raised its stake in Globe Life by 213.7% in the fourth quarter. Strs Ohio now owns 21,907 shares of the company’s stock valued at $3,064,000 after buying an additional 14,924 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on GL. Jefferies Financial Group boosted their price target on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. JPMorgan Chase & Co. lifted their target price on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. TD Cowen boosted their target price on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Finally, Keefe, Bruyette & Woods decreased their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research report on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.